Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

793

Tables (1-3)

255

Sum=1147

Publishing Process of This Article

Item

Count

Browse

153

Download

304

Sum=457

Sep 26, 2022 (publication date) through Apr 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 26, 2022; 10(27): 9650-9656
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9650

Table 2 Comparison of alpha-fetoprotein between the two groups before and after the treatment (mean ± SD, ng/mL)

Citation: Zhang C, Dai YH, Lian SF, Liu L, Zhao T, Wen JY. Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer. World J Clin Cases 2022; 10(27): 9650-9656
URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9650.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i27.9650